Skip to content

An evidence-based study on the effects of colostrum oral immunotherapy on feeding and complications of premature infants

An evidence-based study on the effects of colostrum oral immunotherapy on feeding and complications of premature infants

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2200066209
Enrollment
Unknown
Registered
2022-11-28
Start date
2022-12-01
Completion date
Unknown
Last updated
2023-05-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

premature infant

Interventions

Intervention group:colostrum immune therapy
Control group:warn water oral application

Sponsors

Shenzhen Longgang Maternal and Child Health Hospital
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: (1) Gestational age < 37 weeks; (2) Admitted to the hospital within 24 hours after birth; (3) The mother can provide colostrum; (4) Informed consent of the guardian before the study. If the patient meet the above 4 criteria, he can be included in the study.

Exclusion criteria

Exclusion criteria: (1) Premature infants born with severe deformities requiring surgical operations; (2) Preterm infants whose mothers have a history of substance abuse or HIV or HBV or HCV infection and have contraindications to breastfeeding; (3) Preterm infants with congenital gastrointestinal or kidney abnormalities or severe digestive tract malformations; (4) Preterm infants with early onset sepsis or who received blood transfusion within 24 hours after birth; (5) Preterm infants who received endotracheal intubation during hospitalization. If the patient meet any of the above 5 criteria, he will be excluded.

Design outcomes

Primary

MeasureTime frame
time of first enteral feeding;total enteral feeding time;total oral feeding time;

Secondary

MeasureTime frame
growth rate of head circumference;growth rate of body mass;white blood cell count;CRP;PCT;incidence of infectious diseases;total hospital stay;total number of days requiring oxygen therapy;

Countries

China

Contacts

Public ContactHu Bing

Shenzhen Longgang Maternal and Child Health Hospital

1176593150@qq.com13622369628

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026